Abstract
This article presents two patients with significant minocycline-induced hyperpigmentation, illustrating the diverse clinical manifestations across various body sites. Judicious use of minocycline and early recognition of its adverse effects are crucial to reduce the risk of irreversible hyperpigmentation in patients receiving this antibiotic.